Omthera Pharmaceuticals' Series B Round

Omthera Pharmaceuticals raised a round of funding on March 22, 2011.

Omthera Pharmaceuticals is a specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Omthera is dedicated to developing therapies for pati…

Articles about Omthera Pharmaceuticals' Series B Round: